QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
Log in
NASDAQ:APM

Aptorum Group Stock Forecast, Price & News

$4.76
+3.54 (+290.16 %)
(As of 09/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.68
Now: $4.76
$14.23
50-Day Range
$1.22
MA: $2.20
$3.69
52-Week Range
$1.16
Now: $4.76
$18.25
Volume62.16 million shs
Average Volume421,764 shs
Market Capitalization$137.92 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.25
Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in Central, Hong Kong.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APM
CUSIPN/A
CIKN/A
Phone852-2117-6611

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$540,000.00
Book Value$0.51 per share

Profitability

Miscellaneous

Employees39
Market Cap$137.92 million
Next Earnings DateN/A
OptionableNot Optionable
$4.76
+3.54 (+290.16 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APM News and Ratings via Email

Sign-up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aptorum Group (NASDAQ:APM) Frequently Asked Questions

How has Aptorum Group's stock been impacted by Coronavirus?

Aptorum Group's stock was trading at $2.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, APM shares have increased by 62.5% and is now trading at $4.76.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Aptorum Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aptorum Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aptorum Group
.

Are investors shorting Aptorum Group?

Aptorum Group saw a decrease in short interest in September. As of September 15th, there was short interest totaling 40,200 shares, a decrease of 21.5% from the August 31st total of 51,200 shares. Based on an average daily trading volume, of 189,500 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.8% of the shares of the stock are sold short.
View Aptorum Group's Short Interest
.

Who are some of Aptorum Group's key competitors?

What other stocks do shareholders of Aptorum Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aptorum Group investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Inovio Pharmaceuticals (INO), (MRNA), Sanofi (SNY), Arcturus Therapeutics (ARCT), Aridis Pharmaceuticals (ARDS) and Dynavax Technologies (DVAX).

Who are Aptorum Group's key executives?

Aptorum Group's management team includes the following people:
  • Mr. Chung Yuen Huen, Founder, CEO & Exec. Director (Age 39)
  • Mr. Darren Lui, Pres, Chief Bus. Officer & Exec. Director (Age 38)
  • Ms. Sabrina Khan, Chief Financial Officer (Age 37)
  • Dr. Siu-yan Ng, Chief Operating Officer (Age 38)
  • Mr. Clark Cheng, Chief Medical Officer & Exec. Director (Age 39)

What is Aptorum Group's stock symbol?

Aptorum Group trades on the NASDAQ under the ticker symbol "APM."

How do I buy shares of Aptorum Group?

Shares of APM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aptorum Group's stock price today?

One share of APM stock can currently be purchased for approximately $4.76.

How big of a company is Aptorum Group?

Aptorum Group has a market capitalization of $137.92 million and generates $540,000.00 in revenue each year. Aptorum Group employs 39 workers across the globe.

What is Aptorum Group's official website?

The official website for Aptorum Group is www.aptorumgroup.com.

How can I contact Aptorum Group?

Aptorum Group's mailing address is 17/F GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL, HONG KONG K3, 999077. The company can be reached via phone at 852-2117-6611 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.